• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News

News · February 1, 2022

CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer

centogene

Dr. Andrin Oswald resigns as CEO due to prolonged medical leave; Kim Stratton elected as successor CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene …

News · January 18, 2022

TVM Capital Life Science promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner

Munich, Germany / Montreal, Canada - 12 January 2022 – TVM Life Science (“TVM”), a leading International Life Sciences Venture Capital firm, today announces the formal promotion of Dr. Sascha Berger …

News · January 13, 2022

Syndivia and TVM Capital Life Science Announce Creation of Auricula Biosciences to Develop Innovative Therapy for Patients with K-Ras mutant malignancies

laboratory

Luxembourg, January 13th, 2022 – TVM Life Science Innovation II SCSp announced the Fund's investment establishing Auricula Biosciences, Inc., a company based in Wilmington, Delaware, USA. Auricula …

News · November 22, 2021

Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

laboratory

NEWTON, MA – Nov. 19, 2021 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and …

News · November 16, 2021

Kent Imaging – Setting A New Global Standard in Advanced Tissue Assessment

handheld-kent-imaging

November 16, 2021 Kent Imaging is a market leader in light-based tissue assessment diagnostic devices. The company designs and manufactures imaging technology that supports real-time …

News · November 16, 2021

Nekonal and TVM Capital Life Science Announce Creation of T7 Therapeutics to Develop Innovative Therapy for Patients with Auto-immune diseases

laboratory

Luxembourg, November 15th, 2021 – TVM Life Science Innovation II SCSp announced the Fund's investment establishing T7 Therapeutics, Inc., a company based in Wilmington, Delaware, USA. T7 …

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 51
  • Go to Next Page »

Primary Sidebar

Secondary Sidebar

Additional News

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023

March 17, 2023

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders

February 23, 2023

Esperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQ

February 21, 2023

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.

February 1, 2023

Panthera D-SAD Classic oral appliance now eligible for Medicare reimbursement

August 1, 2022

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact